LSPN 19: AI ‘explosion’ and drug costs in Canada
17-10-2019
LSPN 19: Courts need to revisit patentability of diagnostic tests
26-04-2019
Viktoria Kurpas / Shutterstock.com
In the fast-paced environment of life sciences, the need for the IP sector to take full advantage of potential and emerging innovations is paramount, as a LSPN Connect session discovered.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
LSPN, inventions, life sciences, innovation, patents, COVID-19, trade secrets, confidentiality, R&D, IP education, harvesting, technology
